Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

58.93 +0.39 (+0.67%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

44 45 Next >

Second Most Prevalent Bacterial Sexually Transmitted Infection: GSK's Gonorrhea Vaccine Secures FDA Track ↗

June 27, 2023

The FDA has granted Fast Track designation to GSK plc's (NYSE:

Via Benzinga

Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics ↗

June 26, 2023

As the emergency phase of the COVID-19 pandemic draws to a close, the COVAX initiative, run by Gavi, the WHO, and CEPI, reportedly has $2.6 billion left over that could be used to prepare for other...

Via Benzinga

Is GSK a Strong Buy Right Now? ↗

June 26, 2023

The drugmaker ought to appeal to value and income investors.

Via The Motley Fool

Why Shares of CureVac Jumped This Week ↗

June 23, 2023

The company, which focuses on mRNA therapies, began a phase 1 trial for its cancer vaccine candidate.

Via The Motley Fool

Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 23, 2023

Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'.

Via Benzinga

2 Stocks Defying Friday's Market Downturn ↗

June 23, 2023

Stock markets opened lower as Wall Street took a pause from the bull run.

Via The Motley Fool

GSK Surges After Settling First Zantac Case, But A 'Conveyor Belt' Of Claims Looms ↗

June 23, 2023

GSK settled with James Goetz for an undisclosed amount of money. But thousands of cases remain.

Via Investor's Business Daily

Crypto Analyst Says Bitcoin Can Break $32K Level, Nikola Moves Forward With Test Road Trips Despite Weak Demand & Internal Conflict, Retailers' Subscriptions Under FTC Scrutiny: Today's Top Stories ↗

June 23, 2023

Benzinga

Via Benzinga

GSK Confidentially Settles First Zantac-Associated Cancer Lawsuit Due For US Trial Next Month ↗

June 23, 2023

GSK plc (NYSE: GSK) has reached a confidential settlement with James Goet

Via Benzinga

Trupanion, IonQ, 3M And Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗

June 23, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Intel Voices Plans To Restructure Manufacturing Business, Bumble's BFF App, Spirit AeroSystems To Stop Work At Kansas Plant Amid Workers Strike: Today's Top Stories ↗

June 22, 2023

Reuters

Via Benzinga

RSV Vaccines from Pfizer and GSK Gain CDC Advisory Committee's Favor for Older Adults ↗

June 22, 2023

The US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices voted in favor of recommending the use of RSV vaccines from Pfizer Inc (NYSE: PFE) and GSK...

Via Benzinga

7 Healthcare Stocks to Make You the Millionaire Next Door ↗

June 21, 2023

For investors who want to greatly increase their wealth in the long term, these are the best healthcare stocks to buy.

Via InvestorPlace

US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices votes to recommend AREXVY for the prevention of RSV disease in adults aged 60 and older with shared clinical decision making

June 21, 2023

From GSK plc

Via Business Wire

Pfizer's Elderly Vaccine Efficacy Drops Slightly After 18 Months, New Clinical Trials Reveal - CDC Advisory Panel Set To Vote Today On Recommended Use Of RSV Shots ↗

June 21, 2023

Pfizer Inc's (NYSE: PFE) vaccine for elderly 60 and above was slightly less effective after 18 months, according to the company's clinical trial

Via Benzinga

GSK's Recently Approved Vaccine Offers Long-Term Protection Against RSV in Older Adults, New Data Reveals ↗

June 21, 2023

GSK plc (NYSE: GSK) announced

Via Benzinga

GSK shares positive data for AREXVY, its respiratory syncytial virus (RSV) older adult vaccine, indicating protection over two RSV seasons

June 21, 2023

From GSK plc

Via Business Wire

GSK and Lifetime® Release Short Film Featuring Soleil Moon Frye and Melissa Joan Hart Urging Parents to “Ask2BSure” about Meningitis B

June 20, 2023

From GSK plc

Via Business Wire

Sanofi Stock Is Trading Higher Today - Here's Why ↗

June 20, 2023

Sanofi SA (NASDAQ: SNY) announced that the tribunal dismissed Boehringer Ingelheim's indemnification claim against Sanofi in an International Chamber of Commerce dispute in cancer lawsuits linked to...

Via Benzinga

3 Undervalued Consumer Stocks to Buy in June ↗

June 20, 2023

These undervalued consumer stocks to buy could attract investor attention as possible hedges against inflation and a recession.

Via InvestorPlace

3 Gene Testing Stocks to Buy Before They Take Off ↗

June 17, 2023

The future of gene testing is bright thanks to an aging population. Here are three companies leading the industry.

Via InvestorPlace

UK Gives Nod To Roomba Maker IRobot-Amazon Deal, Micron Plans To Invest In China Despite Restrictions, Baidu Secures Regulatory Nod for Self-Driving Taxi: Today's Top Stories ↗

June 16, 2023

Benzinga

Via Benzinga

2 Top Healthcare Stocks to Buy Right Now ↗

June 16, 2023

The demand for healthcare sector goods and services is both predictable and growing.

Via The Motley Fool

Coherus BioSciences Acquires Small Immuno-Oncology Player Surface Oncology For $40M ↗

June 16, 2023

Coherus BioSciences Inc (NASDAQ: CHRS) has agreed to acquire Surface Oncology Inc (NASDAQ: SURF), a clinical-stage immuno-oncology (I-O) company developing next-generation immunotherapies that

Via Benzinga

FDA Pushes Review Time For GSK's Blood Cancer Therapy Added Via Sierra Oncology Acquisition ↗

June 16, 2023

The FDA has extended the review period for GSK plc's (NYSE:

Via Benzinga

New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action

June 08, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – June 8, 2023 – USA News Group – By utilizing newly developed novel mechanisms, biotech researchers and scientists are making...

Via FinancialNewsMedia

ChatGPT's Parent Has No IPO Plans, CNN CEO Chris Licht Out, Kim Kardashian's Bid To Dismiss EthereumMax Lawsuit Rejected: Today's Top Stories ↗

June 07, 2023

Benzinga Cable Giant CNN Chairman, CEO Chris Licht Moves Out

Via Benzinga

GSK's Arexvy Gets the Green Light in Europe: First-Ever RSV Vaccine in Europe for Older Adults ↗

June 07, 2023

The European Commission has approved GSK plc's (NYSE:

Via Benzinga

June 2023 Stock Considerations ↗

June 07, 2023

With a new trading month already in full swing it is time, once again, to highlight some of my potential stock purchases.

Via Talk Markets

SEC Accuses Binance & Coinbase Of Acting As Unregistered Broker, Binance Takes Biggest Hit As $300M In Crypto Positions Liquidated In 24 Hours, JPMorgan Clarifies CEO Jamie Dimon Not Running For Presidency: Today's Top Stories ↗

June 06, 2023

Benzinga

Via Benzinga

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

44 45 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Starting at $3.75/week.

Subscribe Today